Caxton Associates (New York)’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,963
Closed -$302K 362
2020
Q2
$302K Sell
4,963
-7,358
-60% -$454K 0.03% 258
2020
Q1
$677K Buy
+12,321
New +$826K 0.12% 105
2019
Q2
Sell
-10,199
Closed -$552K 423
2019
Q1
$552K Buy
+10,199
New +$573K 0.08% 130
2018
Q3
Sell
-10,459
Closed -$692K 434
2018
Q2
$692K Buy
+10,459
New +$704K 0.03% 211
2017
Q3
Sell
-11,600
Closed -$748K 518
2017
Q2
$748K Buy
+11,600
New +$732K 0.03% 216
2014
Q2
Sell
-60,000
Closed -$2.79M 194
2014
Q1
$2.79M Buy
60,000
+43,300
+259% +$1.89M 0.17% 101
2013
Q4
$689K Buy
+16,700
New +$657K 0.02% 180
2013
Q3
Sell
-40,600
Closed -$1.51M 182
2013
Q2
$1.51M Buy
+40,600
New +$1.45M 0.08% 120

Other funds holding DOX

Caxton Associates (New York)'s DOX Position: Q3 2020 in Review

Caxton Associates (New York) sold out of Amdocs (DOX) in Q3 2020, closing a stake of 4,963 shares — an estimated $302K sold.

Caxton Associates (New York) first reported a position in DOX in Q2 2013 and held it in 8 quarters. The position peaked at $2.79M in Q1 2014. 395 funds tracked by Wall St. Rank hold DOX as of Q3 2020.

  • Caxton Associates (New York) reported no remaining Amdocs position as of Q3 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,963 Amdocs shares in Q3 2020, an estimated $302K.
  • Caxton Associates (New York) first reported a position in Amdocs in Q2 2013 and held it in 8 quarters.
  • Caxton Associates (New York)'s Amdocs position peaked at $2.79M in Q1 2014.
  • 395 funds tracked by Wall St. Rank held Amdocs as of Q3 2020.

Based on Caxton Associates (New York)'s 13F filing for Q3 2020, filed 16 Nov 2020.